Protective effects of xanthoceraside on learning and memory impairment induced by Aβ25-35 in mice

Journal of Asian Natural Products Research

Volumn 11, Issue 12, 2009, Pages 1019-1027

  Chi, Tian Yan ^a   Wang, Li Hua ^b   Qu, Chan ^a   Yang, Bai Zhen ^b   Ji, Xue Fei ^a   Wang, Yi ^b   Okuyama, Toru ^c   Yoshihito, Okada ^c   Zou, Li Bo ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b INSTITUTE OF APPLIED ECOLOGY   (China)

^c MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

A 25 35; Alzheimer's disease; Learning and memory; Xanthoceraside

Indexed keywords

ACETYLCHOLINESTERASE; AMYLOID BETA PROTEIN[25-35]; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; SAPONIN DERIVATIVE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; XANTHOCERASIDE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HISTOPATHOLOGY; LEARNING DISORDER; MAZE TEST; MEMORY DISORDER; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN;

AMYLOID BETA-PROTEIN; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; MALE; MAZE LEARNING; MEMORY DISORDERS; MICE; MOLECULAR STRUCTURE; PEPTIDE FRAGMENTS; SAPONINS; TRITERPENES;

MUS;

EID: 77949560292     PISSN: 10286020     EISSN: 14772213     Source Type: Journal    
DOI: 10.1080/10286020903337832     Document Type: Article

References (24)

1. A.M. Palmer, Trends Pharmacol. Sci. 23, 426 (2002).
2. B.A. Yankner, Ann. N. Y. Acad. Sci. 924, 26 (2000).
3. C.P. Ferri, M. Prince, C. Brayne, H. Brodaty, L. Fratiglioni, M. Ganguli, K. Hall, K. Hasegawa, H. Hendrie, Y. Huang, A. Jorm, C. Mathers, P.R. Menezes, E. Rimmer, and M. Scazufca, Lancet 366, 2112 (2005).
4. J. Hardy and D.J. Selkoe, Science 297, 353 (2002).
5. J. Hardy and D. Allsop, Trends Pharmacol. Sci. 12, 383 (1991).
6. A. Itoh, A. Nitta, M. Nadai, K. Nishimura, M.Hirose,T.Hasegawa, andT.Nabeshima, J. Neurochem. 66, 1113 (1996).
7. R.H. Zhou, Resource science of Chinese medicinal materials (China Medical Technology Press, Beijing, 1993), Vol.1, p. 331.
8. X.X. Liu, X.F. Ji, L.L. Lu, B.Z. Yang, L.H. Wang, and L.B. Zou, Chin. Tradit. Herb Drugs 38, 1859 (2007).
9. X.F. Ji, X.X. Liu, and Z. Wu, J. Shenyang Pharm. Univ. 24, 232 (2007).
10. X.X. Liu, X.A. Yang, C. Qu, Z. Wu, B.Z. Yang, L.H. Wang, and L.B. Zou, Tradit. Chin. Drug Res. Clin. Pharmacol. 18, 23 (2007).
11. B.J. Cummings, C.J. Pike, R. Shankle, and C.W. Cotman, Neurobiol. Aging. 17, 921 (1996).
12. E.M. Sigurdsson, M.J. Hejna, L.M. Lee, and S.A. Lorens, Behav. Brain Res. 72, 141 (1995).
13. G. Pepeu, L. Giovannelli, F. Casamenti, C. Scali, and L. Bartolini, Prog. Brain Res. 109, 273 (1996).
14. W.A. Dornan, D.E. Kang, A. Mclampbell, and E.E. Kang, Neuroreport 5, 165 (1993).
15. T. Maurice, B.P. Lockhart, and A. Privat, Brain Res. 706, 181 (1996).
16. R.J. Mark, E.M. Blanc, and M.P. Mattson, Mot. Neurobiol. 12, 211 (1996).
17. J. Chu and L. Li, Chin. Pharmacol. Bull. 20, 827 (2004).
18. A.L. Fu, Z.H. Dong, and M.J. Sun, Brain Res. 1109, 201 (2006).
19. Y. Tang, D.X. Yang, W. Gao, J.X. Liu, and X.M. Hu, Chin. Pharmacol. Bull. 20, 1432 (2004).
20. E. Abe, F. Casamenti, L. Giovannelli, C. Scali, and G. Pepeu, Brain Res. 636, 162 (1994).
21. A. Nitta, A. Itoh, T. Hasegawa, and T. Nabeshima, Neurosci. Lett. 170, 63 (1994).
22. A. Nitta and T. Nabeshima, Nihon Shinkei Seishin Yakurigaku Zasshi. 16, 85 (1996).
23. X.Y. Wang, J. Chen, and J.T. Zhang, Acta Pharmacol. Sin. 36, 1 (2001).
24. Z.H. Dong, A.L. Fu, S.J. Huang, and M.W. Sun, Chin. J. Pharm. Toxicol. 20, 39 (2006).